Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001428638-17-000001
Filing Date
2017-01-17
Accepted
2017-01-17 15:40:40
Documents
1
Period of Report
2017-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3328
  Complete submission text file 0001428638-17-000001.txt   5059
Mailing Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401
Business Address 1327 OCEAN AVENUE, SUITE M SANTA MONICA CA 90401 310-899-4442
PARALLAX HEALTH SCIENCES, INC. (Issuer) CIK: 0001388410 (see all company filings)

EIN.: 721619357 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 5912 Retail-Drug Stores and Proprietary Stores

Mailing Address 675 BERING DRIVE, SUITE 675 HOUSTON TX 77057
Business Address
OGDEN JOHN L (Reporting) CIK: 0001428638 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52534 | Film No.: 17530657